Interplay with lipid metabolism: lipid metabolism is known to be dysregulated in many cancers and as a consequence of therapy (e.g. statin or fatty acid synthase inhibitor treatment), and there is recent evidence that tissue-specific lipid metabolism directly impacts the profile of protein lipidation [63]. This evidence concerns the gene FASN and cancer.